Home6919 • TPE
add
Caliway Biopharmaceuticals Co Ltd
Nakaraang pagsara
NT$126.50
Sakop ng araw
NT$118.50 - NT$124.00
Sakop ng taon
NT$54.10 - NT$277.00
Market cap
188.02B TWD
Average na Volume
7.00M
P/E ratio
-
Dividend yield
-
Primary exchange
TPE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (TWD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 12.41M | 32.54% |
Gastos sa pagpapatakbo | 129.69M | -4.18% |
Net na kita | 80.19M | 242.84% |
Net profit margin | 646.17 | 207.77% |
Kita sa bawat share | 0.05 | 266.67% |
EBITDA | -114.79M | 6.66% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (TWD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 4.86B | -49.73% |
Kabuuang asset | 9.47B | -3.03% |
Kabuuang sagutin | 63.66M | -13.62% |
Kabuuang equity | 9.41B | — |
Natitirang share | 1.55B | — |
Presyo para makapag-book | 20.87 | — |
Return on assets | -3.19% | — |
Return on capital | -3.21% | — |
Cash Flow
Net change in cash
| (TWD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 80.19M | 242.84% |
Cash mula sa mga operasyon | -61.00M | -45.21% |
Cash mula sa pag-invest | -2.10B | -0.02% |
Cash mula sa financing | -132.76M | -832.49% |
Net change in cash | -2.22B | -4.33% |
Malayang cash flow | -90.97M | -40.39% |
Tungkol
Itinatag
2012
Website